Dedicated to NPs, PAs and rheumatologists who diagnose and treat arthritis and other musculoskeletal conditions.
|
|
Dedicated to NPs, PAs and rheumatologists who diagnose and treat arthritis and other musculoskeletal conditions.
|
|
key topics
navigation |
OA Knee PainGAIT Study Draws Mixed Reactions On Supplements For OA Knee Pain GAIT Study Draws Mixed Reactions On Supplements For OA Knee Pain News & Trends: GAIT Study Draws Mixed Reactions On Supplements For OA Knee Pain - By Anthony Leone, Associate Editor The Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT), which was recently published in The New England Journal Of Medicine, has sparked controversy within the arthritis community. While the patients in the study were stratified on the basis of pain, Dr. Clegg says the subgroup of patients with moderate ... Pregabalin Gains FDA Approval For Fibromyalgia The 100-patient study, which was recently published in the Journal of Rheumatology, found that 39 percent of patients studied achieved an ACR 20 response at 12 weeks after having subcutaneous injections of adalimumab 40 mg every other week. Revealing RA’s Impact On Sleep: What One Study ShowsBy Aaron Becker, Associate Editor A recent study published in Musculoskeletal Care determined that 35 percent of the rheumatoid arthritis (RA) patients enrolled experienced sleep disruption that ... Conquering Osteoarthritis In Aging Athletes Given the challenges of recognizing and managing osteoarthritis in an aging but active population, this author offers a thorough review of current and emerging treatment options. Studies Show Impact Of Anti-TNF Meds For Ankylosing Spondylitis Studies Show Impact Of Anti-TNF Meds For Ankylosing Spondylitis News & Trends: Studies Show Impact Of Anti-TNF Meds For Ankylosing Spondylitis - By Anthony Leone, Associate Editor Results of a five-year study showed that the majority of patients taking infliximab (Remicade, Centocor) for ankylosing spondylitis safely tolerated the drug and a third of the patients had complete remission without any major side effects. Two recent studies show promising findings in the use of anti-TNF drugs to ... RA Study: Etanercept Shows Sustained Efficacy For Up To Nine Years In assessing 77 patients with early RA and 280 patients with longstanding RA who completed eight years of treatment with etanercept, researchers found that 75 percent of patients with early RA and 76 percent of those with longstanding RA achieved an ACR 20 score. A.L. Study Says: Abatacept Offers Sustained Benefits In RA Patients After two years of receiving treatment with abatacept, patients with RA maintained significant improvements, according to study findings that were presented ... Can Bone Scans Facilitate Early Detection Of Knee Arthritis? Scott Dye, MD, says technetium bone scans can enable practitioners to detect a loss of osseous homeostasis in the knees of athletes who have had sports-related injuries that may increase their risk of developing arthritis in the knee. By recognizing this loss of osseous homeostasis years before the development of radiographically identifiable degenerative arthritis, Dr. Dye says clinicians can encourage patients to pursue simple modifications of activities that may help restore osseous ... New Innovations In Pain Management Given the aging of the population and the increasing prevalence of chronic pain, this author interviews leading researchers and clinicians about new modalities and reemerging medications that may have a significant impact for patients.
|
July 19, 2008
A complimentary CME Webcast Event |
Emerging Concepts In Treating Rheumatoid Arthritis
A Guide To Viscosupplementation For Osteoarthritis Knee Pain
A Guide To Infusion Therapy For Patients With Rheumatoid Arthritis